Progestins and cancer

References

• Grady D, Gebretsadik T, Kerlikowske K, et al. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995; 85:304–13
   PubMed Web of Science ®Google Scholar
• Key TJ. Progestins in postmenopausal women: epidemiological data on relationships with endo-metrial and breast cancer risk. In Sitruk-Ware R, Mishell D, eds. Progestins and Antiprogestins in Clinical Practice. New York: Marcel Dekker, 1999 (in press)
   Google Scholar
• The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. J Am Med Assoc 1996;275:370–5
   PubMed Web of Science ®Google Scholar
• Woo druffJD, Pickar JH for the Menopause Study Group. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. Am J Obstet Gynecol 1994;170:1213–23
   Google Scholar
• Steinberg KK, Thacker SB, Smith SJ, et al. A meta-analysis of oestrogen replacement therapy and the risk of breast cancer. J Am Med Assoc 1991; 265:1985–90
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R, Plu-Bureau G. Progestogen use and breast cancer. In Wren BG, ed. Progress in the Management of Menopause. Carnforth, UK: Parthe-non Publishing, 1997:203–10
   Google Scholar
• Key TJA, Pike MC. The role of estrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24: 29–43
   PubMedGoogle Scholar
• Gambrell RD Jr, Maier R, Sanders B. Decreased incidence of breast cancer in postmenopausal oestrogen and progestogen? Obstet Gynecol 1983; 62:435–43
   Google Scholar
• Nachtigall MJ, Smiler SW, Nachtigall RD, et al. Incidence of breast cancer in a 22 year study of women receiving estrogen—progestin replacement therapy. Obstet Gynecol 1992;80:827–30
   PubMed Web of Science ®Google Scholar
• Bergkvist L, Adami HO, Persson I, et al. The risk of breast cancer after oestrogen and oestrogen/ pro gestogen replacement. N Eng1J Med 1989;321: 293–7
   PubMed Web of Science ®Google Scholar
• Persson I, Yuen J, Bergkvist L, et al. Combined oestrogen—progestogen and breast cancer risk. Lancet 1992;340:1044
   PubMed Web of Science ®Google Scholar
• Ewertz M. Influence of non-contraceptive exoge-nous and endogenous sex hormones on breast can-cer risk in Denmark. Int J Cancer 1988;42:832–8
   PubMed Web of Science ®Google Scholar
• Colditz GA, Hankinson SE, Hunter DJ. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589–93
   Google Scholar
• Newcomb PAA, Longnecker MP, Storer BE. Long term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 1995;142:788–95
   Google Scholar
• Stanford JL, Weiss NS, Voigt LF. Combined estro-gen and pro gestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. J Am Med Assoc 1995;574:137–42
   Google Scholar
• Plu-Bureau G, Le MG, Sitruk-Ware R, et al. Pro-gestogen use and decreased risk ofbreast cancer in a cohort study of premenopausal women with benign breast disease. Br J Cancer 1994;70:270–7
   Google Scholar
• Schindler AE, Campagnoli C, Druckmann R, et al. (European Progestin Club). Aspects of progestin activity on the breast. Maturitas 1998;29:61–5
   PubMed Web of Science ®Google Scholar
• McManus MJ, Welsch CW. The effects of estro-gen, progesterone and human placental lactogen on DNA synthesis on human breast ductal epithe-lium contained in athymic mice. Cancer 1984;54: 1920–7
   PubMed Web of Science ®Google Scholar
• Laidlaw IJ, Clarke RB, Howell A, et al. The prolif-eration of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 1995;136: 164–71
   PubMed Web of Science ®Google Scholar
• Longman SM, Buehring GC. Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth. Cancer 1995;59:281–7
   Google Scholar
• Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcino-genesis. Breast Cancer Res Treat 1982;2:5–73
   PubMedGoogle Scholar
• Cline JM, Soderqvist G, Von Shoultz B. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynolmogus macaques. Am J Obstet Gynecol 1996;174:93–100
   Google Scholar
• Kuttenn F, Fournier S, Durand JC, Mauvais-Jarvis P. Estradiol and progesterone receptors in human breast fibroadenomas. J Clin Endocrinol Metab 1981; 52:1225–9
   Google Scholar
• Catherino WH, Jeng MH, Jordan VC. Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mecha-nism. Br J Cancer 1993;67:945–52
   Google Scholar
• Catherino WH, Jordan VC. Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity. J Steroid Biochem Mol Biol 1995;55:239–46
   PubMed Web of Science ®Google Scholar
• Desreux J, Noel A, Thomas JL, et al. Progestin induced apoptosis of normal human breast cells: an in vivo and in vitro study. Presented at the Eighth International Congress on the Menopause, Sydney, Australia, November 1996; abstr. F173:97
   Google Scholar
• Musgrove EA, Lee CS, Sutherland RL. Progestins both stimulate and inhibit breast cancer cell progression while increasing expression of trans-forming growth factor receptor, c-fos and c-myc genes. Mol Cell Biol 1991;11:5032–43
   Google Scholar
• Ferguson DJP, Anderson TJ. Morphological evalu-ation of cell turnover in relation to the menstrual cycle in the resting human breast. Br J Cancer 1991;44:177–81
   Google Scholar
• Wren BG. Hormonal replacement therapy and breast cancer. Eur Menopause J1995;2:13–19
   Google Scholar
• Chang KJ, Lee TTY, Linares-Cruz G, et al. Influ-ences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril 1995;63:785–91
   Google Scholar
• Foidart JM, Colin C, Denoo X, et al. Estradiol and progesterone regulate the proliferation of human breast epithelial cells. Fertil Steril 1998;69: 963–9
   PubMed Web of Science ®Google Scholar
• Pasqualini JR, Paris J, Sitruk-Ware R, et al. Progestins and breast cancer. J Steroid Biochem Mol Biol 1998;65:225–35
   PubMedGoogle Scholar
• Pasqualini JR, Chetrite G, Nguyen BL, etal. Estrone sulfate-sulfatase and 17-b eta-hydroxysteroid dehydrogenase activities; a hypoth-esis for their role in the evolution of human breast cancer from hormone dependence to hormone independence. J Steroid Biochem Mol Biol 1995;53: 407–12
   PubMed Web of Science ®Google Scholar